1887

Abstract

Due to the absence of easily accessible animal models for the study of hepatitis B virus (HBV), the possibility of using , a monkey originating from Morocco, North Africa, was investigated. Three monkeys were intrahepatically inoculated with a replication-competent head-to-tail HBV DNA plasmid dimer construct. The HBV surface antigen and HBV DNA were detected prior to alanine aminotransferase elevation in the serum of two of three HBV-inoculated monkeys at day 2 post-transfection and persisted for several weeks. This indicates that transfected animals developed markers of HBV infection. In addition, electron microscopy of the serum 3 weeks post-transfection showed the presence of virus particles whose shape and size were similar to complete 42 nm HBV Dane particles. Histological examination of liver tissues also revealed pathological changes not observed in uninfected controls, which strongly suggested acute hepatitis. HBV DNA was also detected by PCR in these monkey livers. Taken together, these results indicate that HBV can successfully replicate in this model and that could be a potentially useful new primate model for the study of HBV replication.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-7-1645
2002-07-01
2020-10-21
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/7/0831645a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-7-1645&mimeType=html&fmt=ahah

References

  1. Bassett S. E., Di Bisceglie A. M., Bacon B. R., Sharp R. M., Govindarajan S., Hubbard G. B., Brasky K. M., Lanford R. E.. 1999; Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees. Hepatology29:1884–1892
    [Google Scholar]
  2. Burrell C. J., Mackay P., Greenaway P. J., Hofschneider P. H., Murray K.. 1979; Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature279:43–47
    [Google Scholar]
  3. Charnay P., Pourcel C., Louise A., Fritsch A., Tiollais P.. 1979; Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proceedings of the National Academy of Sciences, USA76:2222–2226
    [Google Scholar]
  4. Cova L., Fourel I., Vitvitski L., Lambert V., Chassot S., Hantz O., Trepo C.. 1993; Animal models for the understanding and control of HBV and HDV infections. Journal of Hepatology17 (Suppl. 3):S143–S148
    [Google Scholar]
  5. Davis H. L., McCluskie M. J., Gerin J. L., Purcell R. H.. 1996; DNA vaccine for hepatitis B: evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proceedings of the National Academy of Sciences, USA93:7213–7218
    [Google Scholar]
  6. Donnelly J. J., Ulmer J. B., Liu M. A.. 1997; DNA vaccines. Life Sciences60:163–172
    [Google Scholar]
  7. Galibert F., Mandart E., Fitoussi F., Tiollais P., Charnay P.. 1979; Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli . Nature281:646–650
    [Google Scholar]
  8. Hantz O., Ooka T., Vitvitski L., Pichoud C., Trepo C.. 1984; Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases. Antimicrobial Agents and Chemotherapy25:242–246
    [Google Scholar]
  9. Ibrahim F., de The G., Gessain A.. 1995; Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques ( Macaca tonkeana ): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1. Journal of Virology69:6980–6993
    [Google Scholar]
  10. Ishikawa K., Fukasawa M., Tsujimoto H., Else J. G., Isahakia M., Ubhi N. K., Ishida T., Takenaka O., Kawamoto Y., Shotake T.. and others 1987; Serological survey and virus isolation of simian T-cell leukemia/T-lymphotropic virus type I (STLV-I) in non-human primates in their native countries. International Journal of Cancer40:233–239
    [Google Scholar]
  11. Kedda M. A., Kramvis A., Kew M. C., Lecatsas G., Paterson A. C., Aspinall S., Stark J. H., De Klerk W. A., Gridelli B.. 2000; Susceptibility of chacma baboons ( Papio ursinus orientalis ) to infection by hepatitis B virus. Transplantation69:1429–1434
    [Google Scholar]
  12. Lambert V., Chassot S., Kay A., Trepo C., Cova L.. 1991; In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein. Virology185:446–450
    [Google Scholar]
  13. Le Guerhier F., Pichoud C., Guerret S., Chevallier M., Jamard C., Hantz O., Li X. Y., Chen S. H., King I., Trepo C., Cheng Y. C., Zoulim F.. 2000; Characterization of the antiviral effect of 2’,3′-dideoxy-2’,3′-didehydro- β-l-5-fluorocytidine in the duck hepatitis B virus infection model. Antimicrobial Agents and Chemotherapy44:111–122
    [Google Scholar]
  14. Mahieux R., Pecon-Slattery J., Chen G. M., Gessain A.. 1998; Evolutionary inferences of novel simian T lymphotropic virus type 1 from wild-caught chacma ( Papio ursinus ) and olive baboons ( Papio anubis ). Virology251:71–84
    [Google Scholar]
  15. Meertens L., Rigoulet J., Mauclere P., Van Beveren M., Chen G. M., Diop O., Dubreuil G., Georges-Goubot M. C., Berthier J. L., Lewis J., Gessain A.. 2001; Molecular and phylogenetic analyses of 16 novel simian T cell leukemia virus type 1 from Africa: close relationship of STLV-1 from Allenopithecus nigroviridis to HTLV-1 subtype B strains. Virology287:275–285
    [Google Scholar]
  16. Petit M. A., Zoulim F., Capel F., Dubanchet S., Dauguet C., Trepo C.. 1990; Variable expression of preS1 antigen in serum during chronic hepatitis B virus infection: an accurate marker for the level of hepatitis B virus replication. Hepatology11:809–814
    [Google Scholar]
  17. Petit M. A., Buffello-Le Guillou D., Roche B., Dussaix E., Duclos-Vallee J. C., Feray C., Samuel D.. 2001; Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen. Journal of Medical Virology65:493–504
    [Google Scholar]
  18. Rollier C., Sunyach C., Barraud L., Madani N., Jamard C., Trepo C., Cova L.. 1999; Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein. Gastroenterology116:658–665
    [Google Scholar]
  19. Sprengel R., Kuhn C., Manso C., Will H.. 1984; Cloned duck hepatitis B virus DNA is infectious in Pekin ducks. Journal of Virology52:932–937
    [Google Scholar]
  20. Walter E., Keist R., Niederost B., Pult I., Blum H. E.. 1996; Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo . Hepatology24:1–5
    [Google Scholar]
  21. Will H., Cattaneo R., Koch H. G., Darai G., Schaller H., Schellekens H., van Eerd P. M., Deinhardt F.. 1982; Cloned HBV DNA causes hepatitis in chimpanzees. Nature299:740–742
    [Google Scholar]
  22. Will H., Darai G., Deinhardt F., Schellekens H., Schaller H.. 1983; Hepatitis B after infection of a chimpanzee with cloned HBV DNA. Developments in Biological Standardization54:131–133
    [Google Scholar]
  23. Wright T. L., Lau J. Y.. 1993; Clinical aspects of hepatitis B virus infection. Lancet342:1340–1344
    [Google Scholar]
  24. Yan R. Q., Su J. J., Huang D. R., Gan Y. C., Yang C., Huang G. H.. 1996; Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. Journal of Cancer Research and Clinical Oncology122:283–288
    [Google Scholar]
  25. Zoulim F., Trepo C.. 1999; New antiviral agents for the therapy of chronic hepatitis B virus infection. Intervirology42:125–144
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-7-1645
Loading
/content/journal/jgv/10.1099/0022-1317-83-7-1645
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error